Clinical Disease through to Scientific Understanding Flashcards

1
Q

What are the 3 ways of handling data relating to an unusual microbial related phenotype/genotype?

A

Clinical/Epidemiological observation
Population genetics
Phenotypic study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 4 reasons we study unusual microbial phenotype/genotype?

A

Unusual phenotype teaches us something we do not yet know about the pathogen
Bacteria of the same species may not be the same genetically and/or phenotypically
The more we understand how something causes disease, the more able we are to tackle it
Important to public health, drug research etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 2 initial unusual microbial clinical observations?

A

Unusual disease progression or presentation
Outbreak situation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 2 initial unusual microbial diagnostic observations?

A

Bacterial colonies look different
Mixed phenotype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the 2 initial unusual microbial epidemiological observations?

A

Increase in disease in a specific region or during a specific time
Increase in a certain or unusual bacterial genotype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the 4 things we must consider when working back from initial clinical/diagnostic/epidemiological observation?

A

Phenotype
Protein and its translation
Protein function
Gene and its transcription

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In clinical phenotype from (3 - p.2), neutrophils are not migrating towards site of infection. Why may this be? (hint - IL-8)
What bacteria was causing infection?

A

Bacteria may be actively preventing neutrophil migration
IL-8 is a key factor for attracting neutrophils - Bacteria may be targeting this

Streptococcus pyogenes (Strep A)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Explain concept of ELISA assay in context of IL-8
Look at (3 - p.2) and explain what ELISA graph shows

A

You have antibodies specific to what you want to measure the amount of (e.g. IL-8)
- You have a capture antibody that binds IL-8 to coat the bottom of the plate
- You introduce secondary antibody that binds IL-8 (sometimes a 3rd antibody too); Either one has a label that reacts with substrate to produce change in colour or fluorescence etc.

Graph shows that overall, isolates from the throat incubated with IL-8 return more IL-8 than those from the blood
- Isolates from the blood are doing something with the IL-8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does western blot of H292 and IL-8 show? (look at (3 - p.3))
What is used as control and why?

A

Smaller band in samples containing both H292 and IL-8 compared to those with just IL-8 which have a larger band
- In the presence of H292, there is less IL-8 present; H292 releases something to cleave IL-8 – Bands are not disappearing, but rather become smaller

H292 and no IL-8 samples is used as control; See if H292 just secretes something at 6 kDa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Where does H292 cleave IL-8?
Why does this affect western blot results?
How did we discover this?

A

C-terminus α-helix is cleaved off

Antibody for western blot binds this helix; Explains why band is thinner

Reverse-phase high-performance liquid chromatography (HLPC) and mass spectrometry analysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the role of IL-8?
Activated neutrophils shed CD62L; CD62L levels positively correlate with mean fluorescent intensity (MFI) - Subtract MFI from unstimulated neutrophils = ΔMFI
What does decrease in ΔMFI represent?
Look at graph on (3 - p.4) and explain it

A

Activates neutrophils

Decrease in ΔMFI represents neutrophil activation

Incubation with IL-8 activates neutrophils
Incubation with bacterial supernatant does not activate neutrophils
Neutrophils with IL-8 and bacterial supernatant does not activate neutrophils
- Whatever is in the bacterial supernatant prevents activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What do we know about whatever is cleaving IL-8 (hint - supernatant and exponential)
Look at graph on (3 - p.4-5)
What is this ‘thing’ likely to be?

A

It’s present in the culture supernatant
Produced by bacteria during exponential growth

Likely to be an enzyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How can we determine what type of enzyme is cleaving IL-8?
Based on graph in (3 - p.5), what type of enzyme is it?
How can we determine which gene encodes this enzyme?; Which gene is it?

A

Use inhibitors of different types of enzymes and see with which one(s), IL-8 concentration is at the same level as without supernatant

Inhibited by Pefabloc, which is a serine protease inhibitor; Enzyme is a serine protease

Fractionate supernatant by size and test IL-8 degrading activity
Must be 100-150 kDa therefore must be SpyCEP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How did we confirm SpyCEP was likely to be the one cleaving IL-8? (hint - degraders vs non-degraders)

A

Used western blot to detect SpyCEP in culture supernatant of degraders and non-degraders
SpyCEP was only present in isolates that degraded, and absent in non-degraders of IL-8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How could we prove SpyCEP is responsible for the degrading phenotype?

A

Knockout SpyCEP gene, and test to see if IL-8 degrading ability is lost; Then reintroduce SpyCEP gene through complementation to see if degrading function is restored

Several other ways to prove it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Look at A and B in figure on (3 - p.6); What do they show?
Why do we grow both control vector and pcepA in antibiotics?

A

By putting SpyCEP gene into SpyCEP mutant (doesn’t have gene) and also into another species (doesn’t have gene), IL-8 degradation ability is present and it looks like the WT

These plasmids will contain an antibiotic resistance gene so it is essential for the bacteria to keep these to survive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Look at C in figure on (3 - p.6); Why is there less neutrophil migration in pcepA than WT?

A

Plasmid replicates more than chromosome, so you get more copies of SpyCEP so more expression

18
Q

How can we see what could be the underlying cause behind the Degraders vs Non-Degraders phenotype?
What did we see (look at graph in (3 - p.7))
What did we compare expression of cepA of against and what did we see?

A

See if they express the gene differently via qPCR

Non-degraders have much lower expression of SpyCEP compared to degraders

Another virulence factor (hasA) to see if they share regulators
Their expression is positively correlated so they are controlled by the same thing

19
Q

hasA is controlled by CovR/S system; What is it, where is it and how does it work?

A

2 component regulator

CovS sits in membrane, CovR in cytoplasm

CovS senses something and phosphorylates CovR
CovR then dimerises and binds promoter of gene and affects its transcription; Regulates expression

20
Q

How do we know that CovR/S is a negative regulator of SpyCEP?
What 2 things about degraders can we now conclude?

A

Took a strain we knew didn’t produce SpyCEP (can’t detect SpyCEP activity or protein) and deleted CovR/S
Deletion causes presence of SpyCEP and IL-8 degrading activity
- WT has no SpyCEP expression or activity

CovR/S downregulates expression of SpyCEP

Only degraders express and produce the SpyCEP gene

21
Q

By sequencing CovR/S genes in degraders and non-degraders, what did we find?
What does this suggest happens during infection?

A

Degraders had mutated CovS and non-degraders didn’t

Suggests mutations in this gene can arise during infection resulting in strains with high expression of virulence factors like SpyCEP

22
Q

What does phylogenetic tree show?

A

Genetic relationship between isolates

23
Q

How do we identify phylogenetic differences between isolates? (hint - WGS)
How do we draw genetic relationships on a phylogenetic tree?

A

WGS isolates to get alignment of isolates with reference genome
Look for variations/SNPs

Lineages break off at nodes and genetic distance (i.e. number of SNPs) is represented by horizontal lines and their length

24
Q

Differences between rooted and unrooted tree?

A

In a rooted tree, vertical branches are not related to genetic distance (can be as big as you want)
In an unrooted tree, length of all branches is important

25
Q

What does a phylogenetic tree give you an idea of? (hint - strains)

A

How strains are related BUT this must be explored further
How bacteria cause infection and factors that are important – Vaccine or therapy targets

26
Q

Phylogenetic tree will give you an idea of how strains are related but this must be explored further; What 4 things must be considered?

A
  • Differences in expression of factors
  • Differences in whether they even carry the genes
  • Differences in ability to cause disease
  • Differences that have occurred during growth/passage; Artificially introducing changes when isolating from patient and treating them badly when passaging them between plates
27
Q

How can epidemiology be used to observe initial observation?

A

Gives you an overall picture of the population
Monitor changes in disease
- Increases or decreases in frequency
Important because we may have to intervene if there’s an increase

28
Q

How can disease case graphs be useful? (hint - 2 ways)
How can disease variant graphs be useful?

A

Helpful for seeing if vaccines are effective; See if number of cases drops after vaccine introduction
- If we start to see higher cases than normal, we can then begin to think about preparations in hospitals and other areas

Number of cases data can be combined with genomics to see the number of cases across different variants; Helpful to see if vaccines are no longer effective against new strains
- If you start to see increases in disease you could relate it back to potential emergence of new variant

29
Q

What genotype do we use to classify Strep A into groups?
If total number of invasive GAS disease greatly correlates and essentially mirrors the number of invasive GAS disease caused by emm3, what does this suggest?

A

Sequence of emm gene

Suggests emm3 encodes in a large portion of invasive GAS diseases

30
Q

We would want to do whole genome sequencing on isolates around upsurge in iGAS to determine changes in the population
We should sequence isolates from the same genotype; Why?
We should sequence isolates from both outside and inside upsurge period; Why?

A

Limited changes within a population of the same genotype, so if we see an increase in infections caused by a genotype, it suggest something has happened within that genotype to make it more successful – Looking to sequence emm3 in different isolates

See what has changed between these isolates

31
Q

What information should we include on a phylogenetic tree about this infection?

A

Type of infection caused by the isolate
Region of the country the patient/isolate was from
Year/month the isolate was taken; Compare with upsurge

32
Q

A lot of the isolates that were taken from patients during the period of upsurge in disease were associated with Lineage C
How was this lineage different? (hint - virulence factors)

A

Gained 2 new virulence factors:
Superantigen – speC
DNase – spd1

But lost:
Superantigen – ssa

33
Q

What is a super antigen?
What is a DNase
- How can these be measured?
Look at graph in (4 - p.6) about DNA and superantigen; What does it show?

A

Has the ability to activate T cells non-specifically; Massive T-cell activation can cause scarlet fever and toxic shock syndrome
- Incubate it with T cells and they proliferate; Measure ∆Cpm to see how many T cells have proliferated due to super antigen

Degrades DNA
- Measure how much DNA is degraded

34
Q

What can we do to compare virulence factors (superantigens) between lineage C and others? (2 ways)

A

Compare the 2 superantigens directly in an assay; Express them recombinantly

  • Western blot to compare protein expression levels of the 2 superantigens; Isolates are different lineages so different factors need considering
  • Quantitative real time PCR to compare gene expression of the 2 superantigens
35
Q

What did we see after WGS of emm89 isolates from upsurge?

A

Emergence of new genetically divergent clade within emm89

36
Q

What did the clustering of the 229 SNPs in the new clade indicate?
How many regions of recombination?

A

Normally get random SNPs occurring and distributed in the genome; In this case we saw regions with lots of SNPs together – Unusual for this to happen in a short period of time

Indicates the SNP cluster originates from an external source, like another bacteria with same genes and different sequence, and has recombined with the host bacteria chromosome

6 regions of recombination

37
Q

What has changed in the isolates of the new emm89 clade? (hint - 2 regions of recombination)

A

Loss of the genes required to make the hyaluronic acid capsule

Change in a region surrounding 2 toxins; NADase and Streptolysin

38
Q

emm89 isolates have greater growth in blood and greater adherence than non-clade emm89; Why is this?

A

Greater growth due to not having capsule; Strange
Greater adherence as without capsule they are more likely to adhere; emm89 variation shows capsule production level correlates with adherence

39
Q

What does NADase do?
What does NADase assay involve?
- Why is it not very accurate?
Look at the graph in (4); What does it show?

A

Cleaves NAD+

Add in something to make it glow in the dark with UV – Then just scale it relative to eachother e.g. high activity is 5 and low activity is 2
- Measuring by eye

40
Q

What does Streptolysin O do?
What does SLO assay involve?
- Why is it more reliable than NADase assay?
Look at the graph in (4); What does it show?

A

Lyses red blood cells

incubating culture supernatant with red blood cells and measuring the optical density; As the red blood cells lyse the OD will increase
- This assay is more complex than NADase assay so this may explain why there’s more variation; Actually measuring a value

41
Q

Do extra practice on (4)

A